Daptomycin: Difference between revisions
From IDWiki
(Created page with "* Cyclic lipopeptide antibiotic that is active against Gram-positive bacteria * Mechanism of action is to depolarize the cell membrane * Bactericidal Category:Cyclic lipope...") |
No edit summary |
||
| Line 1: | Line 1: | ||
| + | == Background == |
||
| ⚫ | |||
| + | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| + | |||
| + | === Mechanism of Action === |
||
| + | |||
| ⚫ | |||
| + | |||
| + | == Pharmacokinetics and Pharmacodynamics == |
||
| + | |||
| ⚫ | |||
| + | *Distributes well into soft tissues and musculoskeletal system, as well as urine |
||
| + | **Poor CNS penetration |
||
| + | **Good lung penetration, but is inactivated by lung surfactant and should not be used to treat pneumonia |
||
[[Category:Cyclic lipopeptides]] |
[[Category:Cyclic lipopeptides]] |
||
Revision as of 13:59, 21 September 2020
Background
- Cyclic lipopeptide antibiotic that is active against Gram-positive bacteria
Mechanism of Action
- Mechanism of action is to depolarize the cell membrane
Pharmacokinetics and Pharmacodynamics
- Bactericidal
- Distributes well into soft tissues and musculoskeletal system, as well as urine
- Poor CNS penetration
- Good lung penetration, but is inactivated by lung surfactant and should not be used to treat pneumonia
References
- ^ S. Piva, Antonello Di Paolo, Laura Galeotti, Francesco Ceccherini, Francesco Cordoni, Liana Signorini, Tommaso Togni, Amedeo De Nicolò, Frank A. Rasulo, Nazzareno Fagoni, N. Latronico, Antonio D’Avolio. Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis. Neurocritical Care. 2019;31(1):116-124. doi:10.1007/s12028-018-0657-y.
